Clinical Implications of the Contrasting Effects of In Vivo Thrombin Receptor Activation (Protease-Activated Receptor Type 1) on the Human Vasculature**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

John H. Cleator; Douglas E. Vaughan

doi:10.1016/j.jacc.2008.01.037

Clinical Implications of the Contrasting Effects of In Vivo Thrombin Receptor Activation (Protease-Activated Receptor Type 1) on the Human Vasculature^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

John H. Cleator, Douglas E. Vaughan^*

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Editorial › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	1757-1759
Number of pages	3
Journal	Journal of the American College of Cardiology
Volume	51
Issue number	18
DOIs	https://doi.org/10.1016/j.jacc.2008.01.037
State	Published - May 6 2008

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jacc.2008.01.037

Cite this

Cleator, J. H., & Vaughan, D. E. (2008). Clinical Implications of the Contrasting Effects of In Vivo Thrombin Receptor Activation (Protease-Activated Receptor Type 1) on the Human Vasculature^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. Journal of the American College of Cardiology, 51(18), 1757-1759. https://doi.org/10.1016/j.jacc.2008.01.037

Cleator, John H. ; Vaughan, Douglas E. / Clinical Implications of the Contrasting Effects of In Vivo Thrombin Receptor Activation (Protease-Activated Receptor Type 1) on the Human Vasculature^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. In: Journal of the American College of Cardiology. 2008 ; Vol. 51, No. 18. pp. 1757-1759.

@article{adb7d105b31b45259c712c8b71d48833,

title = "Clinical Implications of the Contrasting Effects of In Vivo Thrombin Receptor Activation (Protease-Activated Receptor Type 1) on the Human Vasculature**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.",

author = "Cleator, {John H.} and Vaughan, {Douglas E.}",

year = "2008",

month = may,

day = "6",

doi = "10.1016/j.jacc.2008.01.037",

language = "English (US)",

volume = "51",

pages = "1757--1759",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier USA",

number = "18",

}

Cleator, JH & Vaughan, DE 2008, 'Clinical Implications of the Contrasting Effects of In Vivo Thrombin Receptor Activation (Protease-Activated Receptor Type 1) on the Human Vasculature^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.', Journal of the American College of Cardiology, vol. 51, no. 18, pp. 1757-1759. https://doi.org/10.1016/j.jacc.2008.01.037

Clinical Implications of the Contrasting Effects of In Vivo Thrombin Receptor Activation (Protease-Activated Receptor Type 1) on the Human Vasculature^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. / Cleator, John H.; Vaughan, Douglas E.
In: Journal of the American College of Cardiology, Vol. 51, No. 18, 06.05.2008, p. 1757-1759.

Research output: Contribution to journal › Editorial › peer-review

TY - JOUR

T1 - Clinical Implications of the Contrasting Effects of In Vivo Thrombin Receptor Activation (Protease-Activated Receptor Type 1) on the Human Vasculature**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

AU - Cleator, John H.

AU - Vaughan, Douglas E.

PY - 2008/5/6

Y1 - 2008/5/6

UR - http://www.scopus.com/inward/record.url?scp=43049146222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43049146222&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2008.01.037

DO - 10.1016/j.jacc.2008.01.037

M3 - Editorial

C2 - 18452781

AN - SCOPUS:43049146222

SN - 0735-1097

VL - 51

SP - 1757

EP - 1759

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 18

ER -

Cleator JH, Vaughan DE. Clinical Implications of the Contrasting Effects of In Vivo Thrombin Receptor Activation (Protease-Activated Receptor Type 1) on the Human Vasculature^**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. Journal of the American College of Cardiology. 2008 May 6;51(18):1757-1759. doi: 10.1016/j.jacc.2008.01.037

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this